全文获取类型
收费全文 | 874561篇 |
免费 | 72833篇 |
国内免费 | 2869篇 |
专业分类
耳鼻咽喉 | 12918篇 |
儿科学 | 24771篇 |
妇产科学 | 25251篇 |
基础医学 | 125770篇 |
口腔科学 | 25665篇 |
临床医学 | 77076篇 |
内科学 | 166303篇 |
皮肤病学 | 17068篇 |
神经病学 | 70769篇 |
特种医学 | 35635篇 |
外国民族医学 | 181篇 |
外科学 | 137568篇 |
综合类 | 27576篇 |
现状与发展 | 8篇 |
一般理论 | 264篇 |
预防医学 | 67629篇 |
眼科学 | 20833篇 |
药学 | 66206篇 |
15篇 | |
中国医学 | 2461篇 |
肿瘤学 | 46296篇 |
出版年
2018年 | 7778篇 |
2015年 | 8362篇 |
2014年 | 11905篇 |
2013年 | 17498篇 |
2012年 | 23792篇 |
2011年 | 25015篇 |
2010年 | 14688篇 |
2009年 | 13711篇 |
2008年 | 23346篇 |
2007年 | 25386篇 |
2006年 | 25269篇 |
2005年 | 24881篇 |
2004年 | 24171篇 |
2003年 | 23262篇 |
2002年 | 22312篇 |
2001年 | 36174篇 |
2000年 | 36768篇 |
1999年 | 31205篇 |
1998年 | 9407篇 |
1997年 | 8735篇 |
1996年 | 8633篇 |
1995年 | 8138篇 |
1994年 | 7826篇 |
1992年 | 26735篇 |
1991年 | 26167篇 |
1990年 | 25688篇 |
1989年 | 24733篇 |
1988年 | 23252篇 |
1987年 | 22917篇 |
1986年 | 21778篇 |
1985年 | 21114篇 |
1984年 | 16394篇 |
1983年 | 14003篇 |
1982年 | 8860篇 |
1981年 | 8203篇 |
1980年 | 7671篇 |
1979年 | 16740篇 |
1978年 | 12114篇 |
1977年 | 10181篇 |
1976年 | 9328篇 |
1975年 | 10147篇 |
1974年 | 12641篇 |
1973年 | 12136篇 |
1972年 | 11538篇 |
1971年 | 10685篇 |
1970年 | 10218篇 |
1969年 | 9909篇 |
1968年 | 8900篇 |
1967年 | 8230篇 |
1966年 | 7653篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
133.
134.
135.
136.
A. Caldern‐Larraaga D. L. Vetrano L. Ferrucci S. W. Mercer A. Marengoni G. Onder M. Eriksdotter L. Fratiglioni 《Journal of internal medicine》2019,285(3):255-271
This review discusses the interplay between multimorbidity (i.e. co‐occurrence of more than one chronic health condition in an individual) and functional impairment (i.e. limitations in mobility, strength or cognition that may eventually hamper a person's ability to perform everyday tasks). On the one hand, diseases belonging to common patterns of multimorbidity may interact, curtailing compensatory mechanisms and resulting in physical and cognitive decline. On the other hand, physical and cognitive impairment impact the severity and burden of multimorbidity, contributing to the establishment of a vicious circle. The circle may be further exacerbated by people's reduced ability to cope with treatment and care burden and physicians’ fragmented view of health problems, which cause suboptimal use of health services and reduced quality of life and survival. Thus, the synergistic effects of medical diagnoses and functional status in adults, particularly older adults, emerge as central to assessing their health and care needs. Furthermore, common pathways seem to underlie multimorbidity, functional impairment and their interplay. For example, older age, obesity, involuntary weight loss and sedentarism can accelerate damage accumulation in organs and physiological systems by fostering inflammatory status. Inappropriate use or overuse of specific medications and drug–drug and drug–disease interactions also contribute to the bidirectional association between multimorbidity and functional impairment. Additionally, psychosocial factors such as low socioeconomic status and the direct or indirect effects of negative life events, weak social networks and an external locus of control may underlie the complex interactions between multimorbidity, functional decline and negative outcomes. Identifying modifiable risk factors and pathways common to multimorbidity and functional impairment could aid in the design of interventions to delay, prevent or alleviate age‐related health deterioration; this review provides an overview of knowledge gaps and future directions. 相似文献
137.
Wen Wang Yanmei Liu Chuan Yu Jing Tan Weiyi Xiong Duo Dong 《Expert opinion on drug safety》2020,19(3):339-347
ABSTRACTObjectives: Limited evidence has suggested that cefoperazone-sulbactam causes coagulation disorders and bleeding.Methods: The authors conducted a retrospective study to compare patients receiving cefoperazone-sulbactam versus those treated with cefoperazone-tazobactam or ceftazidime. Propensity-score matching was used to explore whether treatment with cefoperazone-sulbactam increased the risk of prothrombin time (PT) prolongation, coagulation disorders, and bleeding, or decreased platelets (PLT).Results: The cohort included 23,242 patients. Among patients receiving cefoperazone-sulbactam, the risk of PT prolongation, coagulation disorders, decreased PLT, and bleeding was 5.3%, 9.2%, 15.7%, and 4.2%, respectively. Propensity-score matching analyses suggested that cefoperazone-sulbactam increased the risk of PT prolongation (aOR 2.26, 95% CI 1.61–3.18), coagulation disorders (aOR 1.81, 95% CI 1.43–2.30), and decreased PLT (aOR 1.46, 95% CI 1.25–1.72), but not increase bleeding (aOR 1.05, 95% CI 0.79–1.40) compared with ceftazidime. Patients receiving cefoperazone-sulbactam had higher risk of PT prolongation (aOR 1.53, 95% CI 1.11–2.10), coagulation disorders (aOR 1.53, 95% CI 1.21–1.95), but not decreased PLT (aOR 0.93, 95% CI 0.81–1.07) or bleeding (aOR 1.11, 95% CI 0.87–1.42), compared with those receiving cefoperazone-tazobactam.Conclusion: Cefoperazone-sulbactam may be associated with a higher risk of PT prolongation and coagulation disorders compared with cefoperazone-tazobactam and ceftazidime. 相似文献
138.
139.
What have studies of non‐industrialized countries told us about the cause of allergic disease?
下载免费PDF全文
![点击此处可从《Clinical and experimental allergy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A.W. Fogarty 《Clinical and experimental allergy》2015,45(1):87-93
The increase in allergic diseases that was observed in countries that had experienced rapid economic growth since the mid‐20th century initiated a search for environmental exposures that may explain these phenomena that continues to the present day. Societies that are in the earlier stages of the process of industrialization provide an opportunity to compare the initial stages of economic development and the lifestyle changes that may accompany this, with other communities whose way of life may not have changed appreciably for centuries. These studies have consistently demonstrated higher levels of allergic disease in the relatively affluent populations compared with those who maintain a more traditional lifestyle. Environmental changes that have emerged from these studies that may modify the risk of allergic disease include microbial exposures including parasite infection, pollution, diet and obesity. In addition, food and drug allergies represent a neglected area of research in these countries that may be causing a relatively high burden of disease. 相似文献